Ketamine for CRPS: Who It Helps and How Well
How ketamine treats Complex Regional Pain Syndrome: who qualifies, what the evidence shows by CRPS stage, cost, risks, and how it compares to other options. Complex Regional Pain Syndrome turns a healed injury into a limb that burns, swells, and flinches at the touch of a bedsheet — and the usual painkillers often barely move it. That's why so many Treasure Valley patients start researching ketamine for CRPS treatment after sympathetic blocks, nerve medications, and physical therapy have all fallen short. This guide covers who tends to qualify, what the evidence actually supports, how it stacks up against other CRPS options, and what getting started looks like in Boise and Eagle. Quick Answer Ketamine is an anesthetic and NMDA-receptor antagonist used off-label for CRPS, given as a series of low-dose intravenous infusions under medical monitoring. The goal is to quiet the central nervous system's amplified pain signaling — not to cure the condition. Relief, when it happens, is usually partial and temporary, and it varies a lot between individuals. Most pain specialists position it as a second- or third-line option that works best alongside physical therapy, and suitability is decided in a clinical consultation, such as a CRPS treatment consultation in Eagle, Idaho . TL;DR Ketamine blocks the NMDA receptor , a pathway tied to the central sensitization that makes CRPS pain spread and persist. See why CRPS behaves differently from ordinary pain Candidacy is specific , not universal — a confirmed diagnosis, failed first-line care, and a cleared cardiovascular and psychiatric screen all matter. Review the candidacy checklist There is no single FDA-approved CRPS protocol. Clinics use different infusion models, and the model changes the time commitment. Compare the three common protocol models Evidence is stronger for short-term pain scores than for lasting functional gains , which is exactly why rehab pairing is emphasized. Read the evidence breakdown by CRPS stage Off-label use usually means out-of-pocket. Spravato's FDA approval is for depression, not pain. See how cost and insurance actually work In This Article Why Does CRPS Respond to Ketamine When Other Painkillers Fail? Who Is a Good Candidate for Ketamine for CRPS Treatment? What Does a CRPS Ketamine Protocol Actually Look Like? What Does the Evidence Show, by CRPS Stage and Duration? How Does Ketamine Compare to Other CRPS Treatments? What Are the Risks and Side Effects? What Does CRPS Ketamine Treatment Cost, and Will Insurance Cover It? How Do You Get Started With CRPS Ketamine Care in the Treasure Valley? Frequently Asked Questions Why Does CRPS Respond to Ketamine When Other Painkillers Fail? CRPS pain is generated and amplified inside the central nervous system, not only at the injured limb. That's the core reason drugs aimed at tissue inflammation or peripheral nerves so often disappoint. Ketamine works at a different address entirely. Central sensitization refers to a state in which pain-processing neurons in the spinal cord and brain become hyper-responsive, so ordinary input — light touch, cool air, clothing — registers as severe pain. Once that amplification is established, the original injury is no longer the main driver. The wiring is. Ketamine is an NMDA receptor antagonist, meaning it blocks a glutamate receptor involved in how pain signals are relayed and reinforced in the central nervous system. It has a long history in anesthesia and is also used at lower, subanesthetic doses in pain management settings, as described in the clinical monograph on ketamine published on NCBI Bookshelf . Blocking that receptor is the mechanistic rationale pain physicians cite when they consider infusions for neuropathic-type pain syndromes. Opioids, by contrast, act on a separate receptor system. For some people with long-standing CRPS they provide limited benefit, and clinicians also weigh the possibility of opioid-induced hyperalgesia — increased pain sensitivity associated with ongoing opioid exposure. That mismatch between the drug's target and the actual pain mechanism is a recurring theme in why CRPS resists conventional pain treatment . Here's the sequence clinicians are trying to interrupt: Injury or surgery — often minor, sometimes trivial relative to the pain that follows Peripheral nerve irritation — abnormal signaling begins in the affected limb Spinal "wind-up" — repeated input makes dorsal horn neurons progressively more reactive Central sensitization — pain spreads, outlasts healing, and resists peripheral treatments NMDA receptor blockade — the point where ketamine is introduced into the picture Key takeaway: Ketamine is considered for CRPS because it targets central amplification rather than peripheral tissue — a different mechanism than most first-line pain drugs. Who Is a Good Candidate for Ketamine for CRPS Treatment? The strongest candidates have a confirmed CRPS diagnosis, symptoms that haven't responded adequately to first-line care, stable cardiovascular and psychiatric health, and the ability to participate in physical therapy afterward. Candidacy is a clinical decision, made after a full history review — not something you can self-determine from an article. What diagnostic criteria do clinicians use? The Budapest Criteria are the diagnostic standard pain specialists commonly use for CRPS. They require continuing pain disproportionate to the original injury, plus reported symptoms and observed signs across four categories: Sensory — hyperalgesia (heightened pain response) or allodynia (pain from non-painful touch) Vasomotor — temperature differences, skin color changes or asymmetry Sudomotor/edema — swelling, or changes in sweating patterns Motor/trophic — reduced range of motion, weakness, tremor, or changes to hair, nail, and skin texture A clinician also has to rule out other conditions that would better explain the findings. Bringing prior imaging, specialist notes, and any documented block results to your consult makes this step faster. Which factors make someone more likely to be accepted? Documented first-line attempts — physical therapy, gabapentinoids, sympathetic blocks, or topical agents already tried Shorter symptom duration — earlier-stage CRPS is generally prioritized in pain-medicine practice Rehab readiness — a PT plan you can actually engage with after infusions Controlled blood pressure — ketamine can raise blood pressure and heart rate, so this is screened Stable psychiatric status — no active psychosis or untreated substance use disorder A support plan — including a driver for infusion days What typically rules someone out? Common exclusions discussed during screening include pregnancy, severe hepatic disease, conditions involving elevated intracranial or intraocular pressure, uncontrolled hypertension, and a history of ketamine-associated bladder problems (cystitis). Certain cardiac histories require clearance first. Some of these are absolute; others simply mean more workup before a decision. The ketamine clinical monograph on NCBI Bookshelf outlines the contraindications and monitoring considerations clinicians weigh. If you're weighing whether your case fits, a CRPS treatment consultation in Eagle, Idaho is where that assessment happens — including an honest answer if infusions aren't the right next step for you. Key takeaway: Ketamine candidacy for CRPS depends on a confirmed diagnosis, failed first-line care, medical clearance, and a realistic rehab plan — all confirmed in consultation. What Does a CRPS Ketamine Protocol Actually Look Like? There is no single FDA-approved ketamine protocol for CRPS, because the use is off-label. Clinics generally follow one of three broad models, and they differ enormously in dose intensity, time commitment, and setting. Knowing which model a clinic uses is one of the most useful questions you can ask on a first call. Protocol model Dose level Session length Course structure Setting Standard low-dose outpatient series Subanesthetic Under about an hour Repeated sessions over a few weeks Outpatient clinic, monitored Extended multi-hour outpatient infusions Subanesthetic, often escalating Several hours per session Consecutive-day block, sometimes over a week or more Dedicated infusion program Anesthetic-dose "ketamine coma" Anesthetic Continuous, multi-day One-time intensive admission Inpatient/ICU; studied outside routine US outpatient care ⚠️ The anesthetic-dose ("ketamine coma") approach is an intensive-care intervention, not an outpatient service. If a clinic markets anything resembling it in an office setting, treat that as a serious red flag. How is the dose determined? Dosing is weight-based and individualized. Your clinician sets a starting rate, then adjusts based on how you tolerate it — blood pressure response, nausea, and how dissociative the experience feels. Ketamine is administered at doses well below those used for general anesthesia in these pain protocols, with continuous monitoring throughout, consistent with the administration guidance in the NCBI ketamine monograph . Practical elements most CRPS protocols share: A loading phase — a clustered series of infusions rather than a single session A reassessment point — a scheduled check on pain, function, and side effects after the series A maintenance decision — booster infusions scheduled based on how long benefit holds PT coordination — rehab timed to follow infusions, not run independently of them Adjunct medications — some clinics use agents like midazolam or anti-nausea medication to improve tolerability How often are booster infusions scheduled? Booster cadence is set by response, not by a fixed calendar. If relief fades, the interval tightens; if it holds, the interval stretches. Many programs start with a planned reassessment rather than pre-booking a year of appointments, which keeps the plan tied to your actual results. For the mechanics of dosing, infusion rates, and session-by-session structure, we go deeper in our breakdown of how CRPS infusion dosing and protocols actually work . What Does the Evidence Show, by CRPS Stage and Duration? Randomized research on ketamine in CRPS has generally reported short-term reductions in pain scores, with the measured benefit diminishing over the following weeks. Trials have used both continuous multi-day infusions and repeated multi-hour sessions. Two honest caveats belong up front: individual results vary widely, and pain relief in these studies has consistently been easier to demonstrate than lasting improvement in physical function. That gap between pain and function is the single most important thing patients aren't told often enough. It's the whole argument for pairing infusions with rehabilitation rather than treating them as a standalone fix. Early CRPS (Under About 12 Months) Earlier intervention is generally prioritized in pain-medicine practice, on the reasoning that central changes are less entrenched before the condition becomes long-standing. Clinicians often describe a "warm" phase — a limb that's swollen, red, and hot — and a later "cold" phase with a pale, cool, sometimes atrophic limb. Patients in the earlier phase tend to be the ones specialists are most eager to get into aggressive multimodal care quickly, including movement-based therapy. That urgency is about preserving function while it's still preservable. It is not a promise of a particular outcome, and response still varies from person to person. Long-Standing or Cold-Phase CRPS Relief is still considered possible in long-duration CRPS, but expectations should be calibrated differently. In practice, clinicians treating established cases plan for smaller gains, shorter-lived benefit, and a maintenance schedule from the outset rather than a single curative series. That doesn't make treatment pointless. For someone who has lived with a limb they can't tolerate touching, even a partial reduction in pain intensity that creates room for desensitization work